VERA EBITDA
Vera Therapeutics Inc Class A · EBITDA
VERA EBITDA
Latest reported-$107.49Mperiod ending
VERA Quarterly EBITDA (-$2.34M → -$107.49M)
Quarterly EBITDA
High-resolution chart · PNG
VERA ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -107,493,000 | |
| -119,069,000 | |
| -89,057,000 | |
| -78,204,000 | |
| -74,538,000 | |
| -49,817,000 | |
| -41,498,000 | |
| -44,672,000 | |
| -31,781,000 | |
| -26,466,000 | |
| -27,161,000 | |
| -19,155,000 | |
| -18,731,000 | |
| -29,701,000 | |
| -31,795,000 | |
| -24,532,000 | |
| -14,725,000 | |
| -16,958,000 | |
| -16,794,000 | |
| -7,552,000 | |
| -3,387,000 | |
| -4,679,000 | |
| -40,917,250 | |
| -3,723,000 | |
| -3,429,000 | |
| -2,342,000 |